<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35118918</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2167-9223</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>7-8</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</Title><ISOAbbreviation>Amyotroph Lateral Scler Frontotemporal Degener</ISOAbbreviation></Journal><ArticleTitle>Adaptation and norming of the Edinburgh Cognitive and behavioural&#xa0;amyotrophic lateral sclerosis screen (ECAS) for three language groups in South Africa.</ArticleTitle><Pagination><StartPage>532</StartPage><EndPage>541</EndPage><MedlinePgn>532-541</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21678421.2022.2030361</ELocationID><Abstract><AbstractText><i>Objectives:</i> To adapt and translate the Edinburgh Cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS); to generate preliminary normative data for three language groups in South Africa (SA); to assess the convergent validity of the ECAS in SA samples. <i>Methods</i>: The ECAS was linguistically and culturally adapted for Afrikaans-, isiXhosa-, and English-speaking SA adults (<i>n</i>&#x2009;=&#x2009;108, 100, and 53, respectively). Each language group was stratified by age and educational level. Cutoff scores for cognitive impairment were set at the group mean minus two standard deviations (SDs). A pilot sample of ALS patients and controls (<i>n</i>&#x2009;=&#x2009;21 each) were administered the ECAS and an extensive neuropsychological evaluation (NPE) and the Montreal Cognitive Assessment (MoCA) to assess convergent validity. <i>Results</i>: Across the three language groups, the total ECAS cutoff scores ranged from 68 to 97. The ECAS score correlated significantly positively with educational level (<i>p</i>&#x2009;&lt;&#x2009;0.001) and negatively with age (<i>p</i>&#x2009;&lt;&#x2009;0.005). The restricted letter fluency task demonstrated a floor effect, particularly in Afrikaans-speakers. The mean total ECAS score (&#xb1;SD) was similar in ALS patients (103.52&#x2009;&#xb1;&#x2009;11.90) and controls (100.67&#x2009;&#xb1;&#x2009;20.49; <i>p</i>&#x2009;=&#x2009;0.58). Three (14.3%) ALS patients scored below the cutoff for cognitive impairment. Correlations between individual ECAS subtests and analogous NPE tests ranged from weak to moderate. The MoCA score was significantly positively correlated with the ECAS total score (<i>r</i>&#x2009;=&#x2009;0.59; <i>p</i> = &lt; 0.001). <i>Conclusions</i>: The adapted ECAS and associated normative data will aid cognitive screening of African ALS patients. Larger participant numbers are needed to assess the validity of the adapted instrument.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Albertyn</LastName><ForeName>Christine H</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0003-0766-3985</Identifier><AffiliationInfo><Affiliation>Neurology Research Group, UCT Neuroscience Institute, University of Cape Town (UCT), Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>Anneli</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9802-5745</Identifier><AffiliationInfo><Affiliation>Department of Statistical Sciences, Statistical Consulting Service, University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakker</LastName><ForeName>Leonhard A</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0001-5221-5095</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Brain Centre Rudolf Magnus, University Medical Centre Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hlangani</LastName><ForeName>Makhaya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Research Group, UCT Neuroscience Institute, University of Cape Town (UCT), Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Der Walt</LastName><ForeName>Kristien</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1864-1389</Identifier><AffiliationInfo><Affiliation>Neurology Research Group, UCT Neuroscience Institute, University of Cape Town (UCT), Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeilinga</LastName><ForeName>Braam</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0762-2545</Identifier><AffiliationInfo><Affiliation>Neurology Research Group, UCT Neuroscience Institute, University of Cape Town (UCT), Cape Town, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology, and UCT Neuroscience&#xa0;Institute, University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Kevin G F</ForeName><Initials>KGF</Initials><Identifier Source="ORCID">0000-0002-0807-6101</Identifier><AffiliationInfo><Affiliation>Department of Psychology, and UCT Neuroscience&#xa0;Institute, University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heckmann</LastName><ForeName>Jeannine M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-8999-718X</Identifier><AffiliationInfo><Affiliation>Neurology Research Group, UCT Neuroscience Institute, University of Cape Town (UCT), Cape Town, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 NS092091</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Amyotroph Lateral Scler Frontotemporal Degener</MedlineTA><NlmUniqueID>101587185</NlmUniqueID><ISSNLinking>2167-8421</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007802" MajorTopicYN="N">Language</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="Y">Cognition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013019" MajorTopicYN="N" Type="Geographic">South Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">African</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">Edinburgh Cognitive and Behavioural in stead of behavioral ALS screen (ECAS)</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">normative data</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>4</Day><Hour>8</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35118918</ArticleId><ArticleId IdType="doi">10.1080/21678421.2022.2030361</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>